compared to procainamide in an animal arrhythmic model , the antiarrhythmic potency of the n-acetylated metabolite of procainamide ( napa ) was 92 % with respect to dose and 70 % with respect to plasma level .
C0003195
antiarrhythmic
C0033216
procainamide